• PDF / 169,040 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 98 Downloads / 167 Views

DOWNLOAD

REPORT

---

1 S

Diffuse allergy and Fanconi syndrome: 2 case reports In a prospective single site observational study involving 94 patients, two patients [ages and sexes not stated] were described, who developed diffuse allergy or Fanconi syndrome during treatment with lamivudine and dolutegravir for HIV. The patients, who had HIV infection, started receiving dolutegravir and lamivudine [3TC] tablets [dosages and routes not stated]. Two patients discontinued dolutegravir and lamivudine treatment for intolerance due to diffuse allergies at one month and Fanconi syndrome at 6 months, respectively [time to reactions onsets and outcomes not stated]. Khuong-Josses M-A, et al. Bitherapie DTG-lamivudine en vie reelle, tolerance et efficacite. Medecine et Maladies Infectieuses 50 (Suppl.): No. 6, Sep 2020. Available from: 803507657 URL: http://doi.org/10.1016/j.medmal.2020.06.397 [French; summarised from an English abstract]

0114-9954/20/1826-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 17 Oct 2020 No. 1826